{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:27:57Z","timestamp":1781130477628,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ymgmr.2022.100871","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T14:30:50Z","timestamp":1651069850000},"page":"100871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Generation of an in vitro model for peripheral neuropathy in Fabry disease using CRISPR-Cas9 in the nociceptive dorsal root ganglion cell line 50B11"],"prefix":"10.1016","volume":"31","author":[{"given":"Christine R.","family":"Kaneski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Hanover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike H.","family":"Schueler Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2022.100871_bb0005","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.2174\/13816128113199990352","article-title":"Anderson-Fabry disease: a multiorgan disease","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0010","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00439-017-1779-6","article-title":"The human gene mutation database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies","volume":"136","author":"Stenson","year":"2017","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0015","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/jmedgenet-2019-106467","article-title":"Use of a rare disease registry for establishing phenotypic classification of previously unassigned GLA variants: a consensus classification system by a multispecialty Fabry disease genotype\u2013phenotype workgroup","volume":"57","author":"Germain","year":"2020","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123726","article-title":"Mutations in the GLA gene and LysoGb3: is it really Anderson-Fabry disease?","volume":"19","author":"Duro","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0025","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1542\/peds.2004-1678","article-title":"Pediatric Fabry disease","volume":"115","author":"Ries","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgmr.2022.100871_bb0030","series-title":"Fabry Disease: Perspectives from 5 Years of FOS","article-title":"Fabry disease in females: clinical characteristics and effects of enzyme replacement therapy","author":"Deegan","year":"2006"},{"key":"10.1016\/j.ymgmr.2022.100871_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12883-016-0549-8","article-title":"Pain management strategies for neuropathic pain in Fabry disease - a systematic review","volume":"16","author":"Schuller","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0040","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0045","first-page":"61","article-title":"Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapy","volume":"106","author":"Schiffmann","year":"2006","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ymgme.2012.03.010","article-title":"Small fiber neuropathy in Fabry disease","volume":"106","author":"Biegstraaten","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0055","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jmg.20.4.309","article-title":"Involvement of dorsal root ganglia in Fabry\u2019s disease","volume":"20","author":"Gadoth","year":"1983","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neulet.2015.01.084","article-title":"The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain","volume":"594","author":"Choi","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1529-8027.2007.00131.x","article-title":"Immortalization and characterization of a nociceptive dorsal root ganglion sensory neuronal line","volume":"12","author":"Chen","year":"2007","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0070","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2013.11.018","article-title":"Trophic factor and hormonal regulation of neurite outgrowth in sensory neuron-like 50B11 cells","volume":"558","author":"Bhattacherjee","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0075","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymgme.2016.07.010","article-title":"Development of a model system for neuronal dysfunction in Fabry disease","volume":"119","author":"Kaneski","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0080","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0009-8981(81)90384-3","article-title":"Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry\u2019s disease","volume":"112","author":"Mayes","year":"1981","journal-title":"Clin. Chem. Acta"},{"key":"10.1016\/j.ymgmr.2022.100871_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0076-6879(00)12900-3","article-title":"Sphingolipid extraction and analysis by thin-layer chromatography","volume":"312","author":"van Echten-Deckert","year":"2000","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0005-2760(92)90129-J","article-title":"Uptake and metabolism of a fluorescent sulfatide analogue in cultured skin fibroblasts","volume":"1124","author":"Monti","year":"1992","journal-title":"Biochim. Biophys. Acta (BBA) - LIPIDS Lipid Metabolism"},{"key":"10.1016\/j.ymgmr.2022.100871_bb0095","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1194\/jlr.D007294","article-title":"Use of lissamine rhodamine ceramide trihexoside as a functional assay for alpha-galactosidase a in intact cells","volume":"51","author":"Kaneski","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0100","article-title":"A short synthetic peptide mimetic of apolipoprotein A1 mediates cholesterol and globotriaosylceramide efflux from fabry fibroblasts","author":"Schueler","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0105","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1194\/jlr.M100423-JLR200","article-title":"Defects in degradation of blood group a and B glycosphingolipids in Schindler and Fabry diseases","volume":"43","author":"Asfaw","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0110","doi-asserted-by":"crossref","first-page":"28973","DOI":"10.1038\/srep28973","article-title":"CRISP-ID: decoding CRISPR mediated indels by sanger sequencing","volume":"6","author":"Dehairs","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0115","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1007\/s12325-019-01061-x","article-title":"Symptoms and quality of life in patients with fabry disease: results from an international patient survey","volume":"36","author":"Morand","year":"2019","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ymgmr.2022.100871_bb0120","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.39300","article-title":"Characterization of small fiber pathology in a mouse model of Fabry disease","volume":"7","author":"Hofmann","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.ymgmr.2022.100871_bb0125","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916663729","article-title":"Increased expression of Trpv1 in peripheral terminals mediates thermal nociception in Fabry disease mouse model","volume":"12","author":"Lakom\u00e1","year":"2016","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ymgmr.2022.100871_bb0130","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99171","article-title":"Neuropathic pain in a Fabry disease rat model","volume":"3","author":"Miller","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymgmr.2022.100871_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/5954890","article-title":"Emerging role of spinal cord TRPV1 in pain exacerbation","volume":"2016","author":"Choi","year":"2016","journal-title":"Neural Plasticity"},{"key":"10.1016\/j.ymgmr.2022.100871_bb0140","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916646379","article-title":"Comprehensive and differential long-term characterization of the alpha-galactosidase a deficient mouse model of Fabry disease focusing on the sensory system and pain development","volume":"12","author":"\u00dc\u00e7eyler","year":"2016","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ymgmr.2022.100871_bb0145","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1517\/17460440903266829","article-title":"Dorsal root ganglia sensory neuronal cultures: a tool for drug discovery for peripheral neuropathies","volume":"4","author":"Melli","year":"2009","journal-title":"Expert Opin. Drug Discovery"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426922000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426922000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:53:46Z","timestamp":1762001626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426922000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":29,"alternative-id":["S2214426922000313"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100871","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of an in vitro model for peripheral neuropathy in Fabry disease using CRISPR-Cas9 in the nociceptive dorsal root ganglion cell line 50B11","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100871"}}